Lipid Metabolism, Atherogenesis, and Haemostasis in Eskimos: the Role of the Prostaglandin-3 Family
Haemostasis · 2009
DOI: 10.1159/000214314 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Haemostasis, 2009. Verfasst von J Dyerberg und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Blood Coagulation Tests, Inuit, Whole Blood Coagulation Time. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
In Eskimos coronary heart disease is a rarity. This can partly be explained by their favorable plasma lipid levels. An additional factor seems, however, to be that in Eskimo food polyunsaturated fatty acids of the ω-3 series replace those of the ω-6 series. C20:5, ω-3 can be converted by the vessel wall to an antiaggregatory substance, whereas it has no proaggregatory effect on platelets. Consistent with these findings Eskimos were found to have a nearly 2-fold longer bleeding time than Danes. Platelet aggregability, too, was merkedly depressed when exposing platelets from Eskimos to ADP and collagen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Dyerberg, J., & Bang, H. O. (2009). Lipid Metabolism, Atherogenesis, and Haemostasis in Eskimos: the Role of the Prostaglandin-3 Family. Haemostasis. https://doi.org/10.1159/000214314
Vancouver
Dyerberg J, Bang HO. Lipid Metabolism, Atherogenesis, and Haemostasis in Eskimos: the Role of the Prostaglandin-3 Family. Haemostasis. 2009. doi:10.1159/000214314
BibTeX
@article{Dyerberg2009,
author = {Dyerberg, J and Bang, H O},
title = {Lipid Metabolism, Atherogenesis, and Haemostasis in Eskimos: the Role of the Prostaglandin-3 Family},
journal = {Haemostasis},
year = {2009},
doi = {10.1159/000214314}
}
EUVIMED